Kavita Desai

Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial

David Brown, Kavita Desai, Babak Vakili et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 181 citations

Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors

R. Gollamudi, Mohammad H. Ghalib, Kavita Desai et al. · Investigational New Drugs · 2009 · 150 citations · Full text

Viral Replication, Molecular Virology, Intravenous Administration +8

A Phase 1 Open-Label, Accelerated Dose-Escalation Study of the Hypoxia-Activated Prodrug AQ4N in Patients with Advanced Malignancies

Kyriakos P. Papadopoulos, Sanjay Goel, M. Beeram et al. · Clinical Cancer Research · 2008 · 52 citations · Full text

A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients with advanced solid cancers

Sanjay Goel, Kavita Desai, M. Macapinlac et al. · Investigational New Drugs · 2005 · 35 citations

Oncology, Dose Escalation Trial, Medicine +11

GERM CELL TUMOURS

V. Kannan, B. K. Misra, Anila Kapadia et al. · Neuro-Oncology · 2014 · 26 citations · Full text

Germ Cell Tumours, Tumoral Pathology, Germ Cell +9